Breaking 17:20 Gold and silver tumble as dollar surges on Iran war and inflation fears 16:50 Fuel price surge disrupts Easter and spring travel worldwide 16:40 UBS holds $5,600 gold target and calls 17% pullback a buying opportunity 16:20 Rescue operation underway as debris in Iran identified as U.S. F-15E 15:50 AI-powered cyberattacks reach a "pivotal moment," experts warn 15:20 Wedbush holds $600 Tesla target despite disappointing Q1 deliveries 14:50 China's Tianlong-3 rocket fails on maiden flight 13:50 Analysts warn Iran could become a North Korea-style garrison state 13:20 Tether gives investors two weeks to commit to $500 billion valuation round 13:10 Coinbase commits $150 million to protect Bitcoin from quantum computing threats 12:50 Erste Group cuts Toyota to "hold" on tariff drag and slowing US sales 12:40 Arm shares slide as investors lock in gains after AI-driven rally 11:50 Iranian drones strike Kuwait's Mina al-Ahmadi refinery again, sparking fires 11:50 Morocco launches sovereign AI platform to boost industrial transformation 11:35 Tesla posts record sales in South Korea and Australia as oil crisis accelerates EV shift 11:20 European Q1 earnings set to rise 4% as energy sector surges 10:50 Japan warns speculators as yen nears 160 amid escalating Iran conflict 10:20 Anthropic maps 171 emotion-like patterns inside Claude that shape its behavior 09:50 Container ship Safeen Prestige sinks in Strait of Hormuz after weeks ablaze 09:20 Airlines face bankruptcy risk as fuel costs soar amid Middle East conflict 08:50 Fossils in China push back origins of complex animal life by millions of years 08:20 Artemis II crew captures iPhone footage in zero gravity on lunar journey 07:50 JWST finds "forbidden" exoplanet with unexpectedly metal-poor atmosphere 17:50 Global fuel prices surge as Iran conflict disrupts oil markets


Lyme disease vaccine shows over 70 percent efficacy in phase 3 trial

Pfizer and Valneva said their experimental Lyme disease vaccine achieved more than 70 percent efficacy in a large phase 3 clinical trial, marking a significant step toward the first approved human vaccine for the disease in more than two decades. Results from the VALOR trial showed the vaccine was 73.2......

Avian flu outbreaks surge globally as spring migration begins

Avian influenza cases are rising across multiple regions as migratory birds begin their annual spring movement, triggering mass culling operations and tighter biosecurity measures in North America, Europe and Asia. In the United States, more than 14.3 million birds across 84 farms have been infected......

Lilly drug retatrutide shows strong results in diabetes trial

Eli Lilly said its experimental drug retatrutide met all primary and secondary endpoints in a phase 3 clinical trial for type 2 diabetes, delivering significant reductions in blood sugar and body weight over 40 weeks. The TRANSCEND-T2D-1 trial involved 537 adults whose diabetes was not adequately controlled......

Long covid linked to lasting heart and lung damage

Long-term COVID-19, often referred to as long COVID, is associated with persistent and sometimes progressive effects on both the cardiovascular and respiratory systems. Evidence shows that even after the acute infection resolves, underlying inflammation and vascular damage can continue to affect organ......

Plant based diets linked to lower risk of major chronic diseases

A plant-based diet centered on fruits, vegetables, whole grains, nuts, and legumes is associated with reduced risk of several chronic diseases. These benefits are driven by lower inflammation, improved cholesterol levels, better blood sugar control, and positive effects on gut microbiota. Outcomes depend......

Medical cannabis legalization shows mixed public health and safety outcomes

Legalizing medical cannabis presents both public health benefits and risks, with outcomes largely shaped by regulation, access controls, and public education. Evidence from recent studies points to a mixed impact, combining therapeutic advantages with emerging safety concerns. Medical cannabis has demonstrated......

Chronic stress linked to long term health risks across body systems

Chronic stress disrupts normal body functions by maintaining high levels of stress hormones such as cortisol, leading to a range of long-term health risks. Sustained activation of stress responses affects multiple systems, increasing vulnerability to serious medical conditions. Prolonged stress has......

Health research in 2025 advances personalized care and digital monitoring

Health and wellness research in 2025 focuses on personalized interventions, preventive care, and the integration of digital technologies to address aging populations and the growing burden of chronic disease. Time-restricted eating has gained attention as a practical approach to metabolic health. Clinical......

United States and Senegal sign agreement to strengthen Senegal’s health system

The governments of the United States and Senegal have signed a new cooperation agreement aimed at strengthening Senegal’s public health system over the next several years. The memorandum of understanding, signed in Dakar, outlines a five-year partnership designed to improve healthcare services,......

Screen overuse raises alarms over child brain development

Heavy screen exposure in early childhood is drawing increasing scrutiny from doctors, researchers and educators across several countries. What was once treated as a question of parenting habits is now being examined as a public health issue with neurological, educational and social consequences. A growing......

Air pollution linked directly to Alzheimer disease in major US study

Long term exposure to fine particulate air pollution is directly associated with a higher risk of Alzheimer disease, independent of cardiovascular conditions such as stroke and high blood pressure, according to a large scale study of nearly 28 million older Americans published in PLOS Medicine. The......

Compass Pathways reports positive phase 3 results for psilocybin therapy

Compass Pathways said its experimental psilocybin-based treatment, COMP360, met the primary endpoint in its second pivotal phase 3 trial for treatment-resistant depression, moving the company closer to what could become the first US Food and Drug Administration approval of a psilocybin therapy for a......

Modified herpes virus boosts immune attack against deadly brain cancer

A single injection of a genetically engineered herpes virus can reprogram the immune environment of glioblastoma, one of the deadliest forms of brain cancer, by drawing cancer fighting T cells into tumors that have long resisted immunotherapy, researchers reported this week. The findings, published......

  • Fajr
  • Sunrise
  • Dhuhr
  • Asr
  • Maghrib
  • Isha

This website, walaw.press, uses cookies to provide you with a good browsing experience and to continuously improve our services. By continuing to browse this site, you agree to the use of these cookies.